[OS] Emergency Epidemic Investigation Data Collections
No material or nonsubstantive change to a currently approved collection
No
Regular
10/22/2026
table that charts list comparision
Requested
Previously Approved
12/31/2028
12/31/2028
12,000
12,000
6,000
6,000
0
0
The EEI Generic ICR is specifically designed to support CDC mission-critical functions by allowing CDC to deploy to the field to conduct Emergency Epidemic Investigations (EEIs) at the request of, and under the public health authority of, external partners seeking support for a rapid response to urgent public health problems. Recent investigation that have benefited from this EEI Generic ICR included the early response to the COVID 19 Pandemic, Monkeypox outbreak, and E-cigarette or Vaping Use-Associated Lung Injury (EVALI), among other high profile acute public health events. In these situations, insufficient information is available to allow for development of data collection instruments before the response team travels to the field. Data collection instruments and methods must be rapidly created and implemented, usually while investigators are in the field, to direct appropriate public health action. Often specific questions will change or new questions will evolve during the course of the investigation as new information is revealed. While most EEIs involve 2 to 3 weeks of data collection, data collections might take longer. Data collection for investigations conducted under this generic will not exceed 90 days. If data collection is required for a longer period of time, a new request will be submitted to OMB explaining the circumstances for the extended data collection and providing the forms that will be used for that collection (by this point, the content and scope of the inquiry should be clearer).
This Non-Substantive Change Request is submitted to the EEI GenIC approved for [NCEZID] Increased rates of Cladophialophora bantiana cases across the United States, 2020-present. Changes are requested in response to feedback received from state and local health department colleagues to help in data collection efforts. CDC does not consider this to be a substantive change to the survey tool and does not anticipate this change will add to the estimated time it will take for importers to complete the form.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Form 0920-1011 Cladophialophora bantiana Case Report Form_REV 22OCT2026
0920-1011 Change request_increased rates of C. bantiana.docx
RE_ Submission of LULAC Comment Letter — 0920-1011.pdf
[NCEZID] Increased rates of Cladophialophora bantiana cases across the United States, 2020-present